BioArctic Q2: Solid momentum in Leqembi launch - Redeye
Redeye return with a research update following BioArctic's Q2 report and recent events, and largely reiterate our fundamental view, although we make some changes to mainly our near term estimates.
ANNONS
Redeye return with a research update following BioArctic's Q2 report and recent events, and largely reiterate our fundamental view, although we make some changes to mainly our near term estimates.